{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T01:00:49Z","timestamp":1747184449715,"version":"3.40.5"},"reference-count":12,"publisher":"Wiley","license":[{"start":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T00:00:00Z","timestamp":1556755200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Therapy"],"DOI":"10.1111\/dth.12944","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T04:59:22Z","timestamp":1555995562000},"page":"e12944","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effective remission of chidamide on treatment of advanced mycosis fungoides: An unusual case report"],"prefix":"10.1155","author":[{"given":"Yuxuan","family":"Che","sequence":"first","affiliation":[{"name":"Medical OncologyThe Second Affiliated Hospital of Dalian Medical University Dalian China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolei","family":"Ding","sequence":"additional","affiliation":[{"name":"Medical OncologyThe Second Affiliated Hospital of Dalian Medical University Dalian China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jincheng","family":"Song","sequence":"additional","affiliation":[{"name":"Medical OncologyThe Second Affiliated Hospital of Dalian Medical University Dalian China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Medical OncologyThe Second Affiliated Hospital of Dalian Medical University Dalian China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuhua","family":"Sun","sequence":"additional","affiliation":[{"name":"Medical OncologyThe Second Affiliated Hospital of Dalian Medical University Dalian China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0714-6411","authenticated-orcid":false,"given":"Liye","family":"Xu","sequence":"additional","affiliation":[{"name":"Medical OncologyThe Second Affiliated Hospital of Dalian Medical University Dalian China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,5,2]]},"reference":[{"key":"e_1_2_5_2_1","first-page":"1","article-title":"Therapeutic advances in cutaneous T\u2010cell lymphoma","volume":"16","author":"Akilov O. E.","year":"2011","journal-title":"Skin Therapy Letter"},{"key":"e_1_2_5_3_1","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood.V88.7.2385.bloodjournal8872385","article-title":"Mycosis fungoides and Sezary syndrome","volume":"88","author":"Diamandidou E.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_5_4_1","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2015.61.7142","article-title":"Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and S\u00e9zary syndrome: Effect of specific prognostic markers on survival and development of a prognostic model","volume":"33","author":"Scarisbrick J. J.","year":"2015","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_5_5_1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fonc.2018.00198","article-title":"New therapies and immunological findings in cutaneous T\u2010cell lymphoma","volume":"8","author":"Kazuyasu F.","year":"2018","journal-title":"Frontiers in Oncology"},{"key":"e_1_2_5_6_1","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00280-012-1847-5","article-title":"Phase I study of chidamide (CS055\/HBI\u20108000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas","volume":"69","author":"Mei D.","year":"2012","journal-title":"Cancer Chemotherapy and Pharmacology"},{"issue":"4","key":"e_1_2_5_7_1","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00280-011-1766-x","article-title":"Chidamide (CS055\/HBI\u20108000): A new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell\u2010mediated tumor cell cytotoxicity","volume":"69","author":"Ning Z. Q.","year":"2012","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"e_1_2_5_8_1","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and S\u00e9zary syndrome: A proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"110","author":"Olsen E.","year":"2007","journal-title":"Blood"},{"key":"e_1_2_5_9_1","doi-asserted-by":"crossref","first-page":"368","DOI":"10.5114\/pdia.2015.54749","article-title":"Primary cutaneous lymphomas: Diagnosis and treatment","volume":"32","author":"Sokolowska\u2010Wojdylo M.","year":"2015","journal-title":"Post\u0229py Dermatologii i Alergologii"},{"key":"e_1_2_5_10_1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jama.1988.03410010050033","article-title":"Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology","volume":"260","author":"Weinstock M. A.","year":"1988","journal-title":"JAMA"},{"key":"e_1_2_5_11_1","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/ajh.24876","article-title":"Cutaneous T\u2010cell lymphoma: 2017 update on diagnosis, risk\u2010stratification, and management","volume":"92","author":"Wilcox R. A.","year":"2017","journal-title":"American Journal of Hematology"},{"issue":"3","key":"e_1_2_5_12_1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/1568011043352948","article-title":"Quantitative structure\u2010activity relationship study of histone deacetylase inhibitors","volume":"4","author":"Xie A. H.","year":"2004","journal-title":"Current Medicinal Chemistry. Anti\u2010Cancer Agents"},{"issue":"8","key":"e_1_2_5_13_1","article-title":"Increased PRAME\u2010specific CTL killing of acute myeloid leukemia cells by either a novel histone deacetylase inhibitor chidamide alone or combined treatment with decitabine","volume":"8","author":"Yao Y.","year":"2013","journal-title":"PLoS One"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdth.12944","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dth.12944","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dth.12944","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dth.12944","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:54:39Z","timestamp":1671818079000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.12944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,2]]},"references-count":12,"alternative-id":["10.1111\/dth.12944"],"URL":"https:\/\/doi.org\/10.1111\/dth.12944","archive":["Portico"],"relation":{},"ISSN":["1396-0296","1529-8019"],"issn-type":[{"type":"print","value":"1396-0296"},{"type":"electronic","value":"1529-8019"}],"subject":[],"published":{"date-parts":[[2019,5,2]]}}}